| Jeffrey M. Soinski |
Jeffrey M. Soinski is currently the President, Chief Executive Officer & Director at Avinger, Inc. since 2018. He is also the CEO & Board Member at Unisyn, Inc. since 2009 and an Investment Partner at Galen Management LLC since 2008. Previously, he served as the President & CEO at Specialized Health Products International, Inc. from 2001 to 2008 and as the Managing Partner & CEO at Mad Dogs & Englishmen, Inc. from 2000 to 2001. He was also the Chief Executive Officer at Mad Dogs & Englishmen, Inc. during the same period. Additionally, he held the position of President & Chief Executive Officer at ViroTex Corp. Furthermore, he served as the Chief Executive Officer at Consensys Imaging Service, Inc. in 2009 and as an Independent Director at Merriman Holdings, Inc. from 2011 to 2016. He also served as an Independent Director at QSAM Biosciences, Inc. and held a marketing executive position at Nabisco Holdings Corp. Mr. Soinski completed his undergraduate degree at Dartmouth College. |
| Nabeel Subainati |
Nabeel Subainati is currently the Chief Financial Officer, CAO & VP-Finance at Avinger, Inc. He previously worked as a Controller at Sigma Designs, Inc. from 2014 to 2018 and at CrossBar, Inc. from 2018 to 2020. Mr. Subainati completed his undergraduate degree at Santa Clara University. |
| Jaafer Golzar |
Jaafer Golzar is currently the Director of Limb Salvage & Endovascular Intervention at Advocate Trinity Hospital and the Chief Medical Officer at Avinger, Inc. He previously worked as the Medical Director of Interventional Vascular at BTG International Ltd. Golzar received his undergraduate degree from The University of Arkansas and his doctorate from Uams College of Medicine. |
| Philip R. Preuss |
Philip R. Preuss is currently the Chief Commercial Officer at Avinger, Inc. He started this position in 2023. Previously, he worked as a Senior Associate-Corporate Development at FoxHollow Technologies, Inc. in 2007 and as the Chief Financial Officer at Siren Care, Inc. in 2020. Mr. Preuss completed his undergraduate degree at Stanford University and holds an MBA from Kellogg School of Management. |
| Himanshu N. Patel |
Himanshu N. Patel is the founder. In 2007, he founded Avinger, Inc. where he holds the title of Chief Technology Officer since 2013. Mr. Patel's former job was as Director-Advanced Technologies at FoxHollow Technologies, Inc. from 1999 to 2007. Mr. Patel's education history includes a graduate degree from the University of Florida and an undergraduate degree from the University of Baroda. |
| James G. Cullen |
James G. Cullen is currently the Non-Executive Chairman at Avinger, Inc. and an Independent Director at Keysight Technologies, Inc. He is also a Director at Eisenhower Health and the Rutgers University Foundation. Previously, Mr. Cullen served as the President & Chief Executive Officer at Bell Atlantic New Jersey, Inc. from 1989 to 1993. He was also the Non-Executive Chairman at Agilent Technologies, Inc. from 2005 to 2017. Additionally, he held the position of Vice Chairman, President & Chief Operating Officer at Bell Atlantic Corp. from 1993 to 2000. From 2010 to 2017, he served as the Chairman of NeuStar, Inc. He was an Independent Director at Johnson & Johnson from 1995 to 2015. Mr. Cullen was also an Independent Director at Prudential Financial, Inc. from 2001 to 2017. In terms of education, Mr. Cullen holds a graduate degree from the Massachusetts Institute of Technology and an undergraduate degree from Rutgers State University of New Jersey. |
| Zhong Zhao |
Zhong Zhao is the founder of Zylox-Tonbridge Medical Technology Co., Ltd. where he currently holds the title of Chairman & Chief Executive Director since 2012. He is also currently working as an Independent Director at Avinger, Inc. since 2024. Previously, Dr. Zhao worked as an Associate Director at Guilford Pharmaceuticals, Inc. from 1996 to 2002 and as a Principal Scientist at Cordis Corp. from 2002 to 2011. He obtained his doctorate degree from The Johns Hopkins University School of Medicine in 1997. |
| James B. McElwee |
James B. McElwee is currently a Director at Micro Power Electronics, Inc., a Director at Silego Technology, Inc., an Independent Director at Avinger, Inc., Secretary & Director at HealthRIGHT 360, a Trustee at Claremont McKenna College, and a Trustee at SFJAZZ. He has formerly held positions as a Director at Wild Oats Markets, Inc., a Director at DTS, Inc., a Director at Purcell Systems, Inc., a Director at NextMedia Group, Inc., a Director at Robb Report Media LLC, and a Senior Consultant at Accenture LLP. He was also a Partner at Weston Presidio Service Co. LLC from 1992 to 2010. McElwee received his undergraduate degree from Claremont McKenna College and his MBA from The Wharton School of the University of Pennsylvania. |
| Tamara N. Elias |
Tamara N. Elias is currently serving as a Director at REVA Medical, Inc., an Independent Director at Avinger, Inc., and an Independent Director at BehaVR, Inc. She previously served as the Chief Executive Officer at Rinat Neuroscience Corp., Director at Medtronic ATS Medical, Inc., Director at Millennium Pharmacy Systems, Inc., Director at Influence Health, Inc., Director at BreatheAmerica, Inc., VP-Corporate Strategy & Business Development at Becton, Dickinson & Co., Vice President & Head-Global Partnerships at Merck & Co., Inc., Vice President-Clinical Product Development at Aetna, Inc., Senior Manager at McKinsey & Co., Inc., Principal at The General Hospital Corp., Principal at Essex Woodlands Management, Inc., and Senior VP-Strategy & Business Incubation at Nuance Communications, Inc. She received her undergraduate degree from Yale University and her doctorate from The Johns Hopkins University School of Medicine. |
